Aardvark Therapeutics, Inc. Common Stock AARD Balance Sheet Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| $47.05M-23.7% | $61.64M— | ||
| $62.98M+424% | $12.02M— | ||
| $111.89M+50.9% | $74.14M— | ||
| $117.18M+51.2% | $77.51M— | ||
| $14.13M+642% | $1.9M— | ||
| $10.55M+114% | $4.93M— | ||
| $10.55M+95.6% | $5.39M— | ||
| $0— | $0— | ||
| -$115.92M-98.7% | -$58.33M— | ||
| $106.63M+295% | -$54.64M-57.0% | ||
| $117.18M+51.2% | $77.51M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Aardvark Therapeutics, Inc. Common Stock's total assets?
- Aardvark Therapeutics, Inc. Common Stock (AARD) holds $98.6M in total assets, down 37.2% year over year.
- How much debt does Aardvark Therapeutics, Inc. Common Stock have?
- Aardvark Therapeutics, Inc. Common Stock carries $336.0K in total debt against $87.0M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Aardvark Therapeutics, Inc. Common Stock have?
- Aardvark Therapeutics, Inc. Common Stock holds $62.4M in cash and equivalents.
- Can Aardvark Therapeutics, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 8.06 — current assets exceed current liabilities.
- Where does Aardvark Therapeutics, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Aardvark Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.